Biology subjects

Myers, C. L.

Publications and source records attributed to Myers, C. L..

11 recordsLinked to original sources

bioRxiv2018

Identification of candidate genes underlying nodulation-specific phenotypes in Medicago truncatula through integration of genome-wide association studies and co-expression networks

Genome-wide association studies (GWAS) have proven to be a valuable approach for identifying genetic intervals associated with phenotypic variation in Medicago truncatula. These intervals can vary in size, depending on the historical local recombination near each significant interval. Typically, significant intervals span numerous gene models, limiting the ability to resolve high-confidence candidate genes underlying the trait of interest. Additional genomic data, including gene co-expression networks, can be combined with the genetic mapping information to successfully identify candidate genes. Co-expression network analysis provides information about the functional relationships of each gene through its similarity of expression patterns to other well-defined clusters of genes. In this study, we integrated data from GWAS and co-expression networks to pinpoint candidate genes that may be associated with nodule-related phenotypes in Medicago truncatula. We further investigated a subset of these genes and confirmed that several had existing evidence linking them nodulation, including MEDTR2G101090 (PEN3-like), a previously validated gene associated with nodule number.

systems biology↗

bioRxiv2018

Domain Insertion Permissibility is a Measure of Engineerable Allostery in Ion Channels

Allostery is a fundamental principle of protein regulation that remains poorly understood and hard to engineer, in particular in ion channels. Here we use human Inward Rectifier K+ Channel Kir2.1 to establish domain insertion permissibility as a new experimental paradigm to identify engineerable allosteric sites. We find that permissibility is best explained by dynamic protein properties, such as conformational flexibility. Many allosterically regulated sites in Kir2.1 or sites equivalent to those regulated in homologs, such as G-protein-gated inward rectifier K+ channels (GIRK), have differential permissibility; that is, for these sites permissibility depends on the structural properties of the inserted domain. Our data and the well-established link between protein dynamics and allostery led us to propose that differential permissibility is a metric of both existing and latent allostery in Kir2.1. In support of this notion, inserting light-switchable domains into either existing or latent allosteric sites, but not elsewhere, renders Kir2.1 activity sensitive to light.

biochemistry↗

bioRxiv2017

Chemical genomic guided engineering of gamma-valerolactone tolerant yeast

BackgroundGamma valerolactone (GVL) is a promising technology for degradation of biomass for biofuel production; however, GVL has adverse toxicity effects on fermentative microbes. Using a combination of chemical genomics and chemical proteomics we sought to understand the mechanism toxicity and resistance to GVL with the goal of engineering a GVL-tolerant, xylose-fermenting yeast.\n\nResultsChemical genomic profiling of GVL predicted that this chemical affects membranes and membrane-bound processes. We show that GVL causes rapid, dose-dependent cell permeability, and is synergistic with ethanol. Chemical genomic profiling of GVL revealed that deletion of the functionally related enzymes Pad1p and Fdc1p, which act together to decarboxylate phenolic acids to vinyl derivatives, increases yeast tolerance to GVL. Further, overexpression of Pad1p sensitizes cells to GVL toxicity. To improve GVL tolerance, we deleted PAD1 and FDC1 in a xylose-fermenting yeast strain. The modified strain exhibited increased anaerobic growth, sugar utilization, and ethanol production in synthetic hydrolysate with 1.5% GVL, and under other conditions. Chemical proteomic profiling of the engineered strain revealed that enzymes involved in ergosterol biosynthesis were more abundant in the presence of GVL compared to the background strain. The engineered GVL strain contained greater amounts of ergosterol than the background strain.\n\nConclusionsWe found that GVL exerts toxicity to yeast by compromising cellular membranes, and that this toxicity is synergistic with ethanol. Deletion of PAD1 and FDC1 conferred GVL resistance to a xylose-fermenting yeast strain by increasing ergosterol content in cells. The GVL-tolerant strain fermented sugars in the presence of GVL levels that were inhibitory to the unmodified strain. This strain represents a xylose fermenting yeast specifically tailored to GVL produced hydrolysates

bioengineering↗

bioRxiv2017

Discovering genetic interactions bridging pathways in genome-wide association studies

Genetic interactions have been reported to underlie phenotypes in a variety of systems, but the extent to which they contribute to complex disease in humans remains unclear. In principle, genome-wide association studies (GWAS) provide a platform for detecting genetic interactions, but existing methods for identifying them from GWAS data tend to focus on testing individual locus pairs, which undermines statistical power. Importantly, the global genetic networks mapped for a model eukaryotic organism revealed that genetic interactions often connect genes between compensatory functional modules in a highly coherent manner. Taking advantage of this expected structure, we developed a computational approach called BridGE that identifies pathways connected by genetic interactions from GWAS data. Applying BridGE broadly, we discovered significant interactions in Parkinsons disease, schizophrenia, hypertension, prostate cancer, breast cancer, and type 2 diabetes. Our novel approach provides a general framework for mapping complex genetic networks underlying human disease from genome-wide genotype data.

genetics↗

bioRxiv2017

Efficient strategies for screening large-scale genetic interaction networks

Large-scale genetic interaction screening is a powerful approach for unbiased characterization of gene function and understanding systems-level cellular organization. While genome-wide screens are desirable as they provide the most comprehensive interaction profiles, they are resource and time-intensive and sometimes infeasible, depending on the species and experimental platform. For these scenarios, optimal methods for more efficient screening while still producing the maximal amount of information from the resulting profiles are of interest.\n\nTo address this problem, we developed an optimal algorithm, called COMPRESS-GI, which selects a small but informative set of genes that captures most of the functional information contained within genome-wide genetic interaction profiles. The utility of this algorithm is demonstrated through an application of the approach to define a diagnostic mutant set for large-scale chemical genetic screens, where more than 13,000 compound screens were achieved through the increased throughput enabled by the approach. COMPRESS-GI can be broadly applied for directing genetic interaction screens in other contexts, including in species with little or no prior genetic-interaction data.

systems biology↗

bioRxiv2017

Evaluation and Design of Genome-wide CRISPR/Cas9 Knockout Screens

The adaptation of CRISPR/Cas9 technology to mammalian cell lines is transforming the study of human functional genomics. Pooled libraries of CRISPR guide RNAs (gRNAs), targeting human protein-coding genes and encoded in viral vectors, have been used to systematically create gene knockouts in a variety of human cancer and immortalized cell lines, in an effort to identify whether these knockouts cause cellular fitness defects. Previous work has shown that CRISPR screens are more sensitive and specific than pooled library shRNA screens in similar assays, but currently there exists significant variability across CRISPR library designs and experimental protocols. In this study, we re-analyze 17 genome-scale knockout screens in human cell lines from three research groups using three different genome-scale gRNA libraries, using the Bayesian Analysis of Gene Essentiality (BAGEL) algorithm to identify essential genes, to refine and expand our previously defined set of human core essential genes, from 360 to 684 genes. We use this expanded set of reference Core Essential Genes (CEG2), plus empirical data from six CRISPR knockout screens, to guide the design of a sequence-optimized gRNA library, the Toronto KnockOut version 3.0 (TKOv3) library. We demonstrate the high effectiveness of the library relative to reference sets of essential and nonessential genes as well as other screens using similar approaches. The optimized TKOv3 library, combined with the CEG2 reference set, provide an efficient, highly optimized platform for performing and assessing gene knockout screens in human cell lines.

systems biology↗

bioRxiv2017

Large-scale interpretation of chemical-genetic interaction profiles using a genetic interaction network

Chemical-genetic interactions - observed when the treatment of mutant cells with chemical compounds reveals unexpected phenotypes - contain rich functional information linking compounds to their cellular modes of action. To systematically identify these interactions, an array of mutants is challenged with a compound and monitored for fitness defects, generating a chemical-genetic interaction profile that provides a quantitative, unbiased description of the cellular function(s) perturbed by the compound. Genetic interactions, obtained from genome-wide double-mutant screens, provide a key for interpreting the functional information contained in chemical-genetic interaction profiles. Despite the utility of this approach, integrative analyses of genetic and chemical-genetic interaction networks have not been systematically evaluated. We developed a method, called CG-TARGET (Chemical Genetic Translation via A Reference Genetic nETwork), that integrates large-scale chemical-genetic interaction screening data with a genetic interaction network to predict the biological processes perturbed by compounds. CG-TARGET compared favorably to a baseline enrichment approach across a variety of benchmarks, achieving similar accuracy while substantially improving the ability to control the false discovery rate of biological process predictions. We applied CG-TARGET to a recent screen of nearly 14,000 chemical compounds in Saccharomyces cerevisiae, integrating this dataset with the global S. cerevisiae genetic interaction network to prioritize over 1500 compounds with high-confidence biological process predictions for further study. Upon investigation of the compatibility of chemical-genetic and genetic interaction profiles, we observed that one-third of observed chemical-genetic interactions contributed to the highest-confidence biological process predictions and that negative chemical-genetic interactions overwhelmingly formed the basis of these predictions. We present here a detailed characterization of the CG-TARGET method along with experimental validation of predicted biological process targets, focusing on inhibitors of tubulin polymerization and cell cycle progression. Our approach successfully demonstrates the use of genetic interaction networks in the functional annotation of compounds to biological processes.

systems biology↗

bioRxiv2017

Systematic identification of pleiotropic genes from genetic interactions

Modular structures in biological networks are ubiquitous and well-described, yet this organization does not capture the complexity of genes individually influencing many modules. Pleiotropy, the phenomenon of a single genetic locus with multiple phenotypic effects, has previously been measured according to many definitions, which typically count phenotypes associated with genes. We take the perspective that, because genes work in complex and interconnected modules, pleiotropy can be treated as a network-derived characteristic. Here, we use the complete network of yeast genetic interactions (GI) to measure pleiotropy of nearly 2700 essential and nonessential genes. Our method uses frequent item set mining to discover GI modules, annotates them with high-level processes, and uses entropy to measure the functional spread of each genes set of containing modules. We classify genes whose modules indicate broad functional influence as having high pleiotropy, while genes with focused functional influence have low pleiotropy. These pleiotropy classes differed in a number of ways: high-pleiotropy genes have comparatively higher expression variance, higher protein abundance, more domains, and higher copy number, while low pleiotropy genes are more likely to be in protein complexes and have many curated phenotypes. We discuss the implications of these results regarding the nature and evolution of pleiotropy.

genomics↗

bioRxiv2017

Improving prediction of compound function from chemical structure using chemical-genetic networks

The drug discovery process can be significantly improved through understanding how the structure of chemical compounds relates to their function. A common paradigm that has been used to filter and prioritize compounds is ligand-based virtual screening, where large libraries of compounds are queried for high structural similarity to a target molecule, with the assumption that structural similarity is predictive of similar biological activity. Although the chemical informatics community has already proposed a wide range of structure descriptors and similarity coefficients, a major challenge has been the lack of systematic and unbiased benchmarks for biological activity that covers a broad range of targets to definitively assess the performance of the alternative approaches.\n\nWe leveraged a large set of chemical-genetic interaction data from the yeast Saccharomyces cerevisiae that our labs have recently generated, covering more than 13,000 compounds from the RIKEN NPDepo and several NCI, NIH, and GlaxoSmithKline (GSK) compound collections. Supportive of the idea that chemical-genetic interaction data provide an unbiased proxy for biological functions, we found that many commonly used structural similarity measures were able to predict the compounds that exhibited similar chemical-genetic interaction profiles, although these measures did exhibit significant differences in performance. Using the chemical-genetic interaction profiles as a basis for our evaluation, we performed a systematic benchmarking of 10 different structure descriptors, each combined with 12 different similarity coefficients. We found that the All-Shortest Path (ASP) structure descriptor paired with the Braun-Blanquet similarity coefficient provided superior performance that was robust across several different compound collections.\n\nWe further describe a machine learning approach that improves the ability of the ASP metric to capture biological activity. We used the ASP fingerprints as input for several supervised machine learning models and the chemical-genetic interaction profiles as the standard for learning. We found that the predictive power of the ASP fingerprints (as well as several other descriptors) could be substantially improved by using support vector machines. For example, on held-out data, we measured a 5-fold improvement in the recall of biologically similar compounds at a precision of 50% based upon the ASP fingerprints. Our results generally suggest that using high-dimensional chemical-genetic data as a basis for refining chemical structure descriptors can be a powerful approach to improving prediction of biological function from structure.

systems biology↗

bioRxiv2017

MOSAIC: a chemical-genetic interaction data repository and web resource for exploring chemical modes of action

SummaryChemical-genomic approaches that map interactions between small molecules and genetic perturbations offer a promising strategy for functional annotation of uncharacterized bioactive compounds. We recently developed a new high-throughput platform for mapping chemical-genetic (CG) interactions in yeast that can be scaled to screen large compound collections, and we applied this system to generate CG interaction profiles for more than 13,000 compounds. When integrated with the existing global yeast genetic interaction network, CG interaction profiles can enable mode-of-action prediction for previously uncharacterized compounds as well as discover unexpected secondary effects for known drugs. To facilitate future analysis of these valuable data, we developed a public database and web interface named MOSAIC. The website provides a convenient interface for querying compounds, bioprocesses (GO terms), and genes for CG information including direct CG interactions, bioprocesses, and gene-level target predictions. MOSAIC also provides access to chemical structure information of screened molecules, chemical-genomic profiles, and the ability to search for compounds sharing structural and functional similarity. This resource will be of interest to chemical biologists for discovering new small molecule probes with specific modes-of-action as well as computational biologists interested in analyzing CG interaction networks.\n\nAvailabilityMOSAIC is available at http://mosaic.cs.umn.edu.\n\nContactchadm@umn.edu, charlie.boone@utoronto.ca, yoshidam@riken.jp, or hisyo@riken.jp

bioinformatics↗

bioRxiv2017

Functional Annotation of Chemical Libraries across Diverse Biological Processes

Chemical-genetic approaches offer the potential for unbiased functional annotation of chemical libraries. Mutations can alter the response of cells to a compound, revealing chemical-genetic interactions that can elucidate a compounds mode of action. We developed a highly parallel and unbiased yeast chemical-genetic screening system involving three key components. First, in a drug-sensitive genetic background, we constructed an optimized, diagnostic mutant collection that is predictive all major yeast biological processes. Second, we implemented a multiplexed (768-plex) barcode sequencing protocol, enabling assembly of thousands of chemical-genetic profiles. Finally, based on comparison of the chemical-genetic profiles with a compendium of genome-wide genetic interaction profiles, we predicted compound functionality. Applying this high-throughput approach, we screened 7 different compound libraries and annotated their functional diversity. We further validated biological process predictions, prioritized a diverse set of compounds, and identified compounds that appear to have dual modes of action.

systems biology↗